Skip to main content

Celebrating Science, Visionaries, and Impact: The New York Academy of Sciences’ 2026 Spring Soirée

A woman presents to a banquet hall full of people.

The New York Academy of Sciences’ 2026 Spring Soirée brought together leaders across academia, industry, and philanthropy to celebrate science and recognize outstanding contributions to the public good. As the Academy’s flagship fundraising event, the evening helped raise sorely needed funds to advance science programming and education, and to nurture future scientific leaders, while honoring six distinguished awardees.

Published April 24, 2026

By Kamala Murthy

On April 21, 2026, The New York Academy of Sciences hosted its second annual 2026 Spring Soirée — the Academy’s flagship fundraising event of the year — welcoming guests from across New York City’s robust science, business, media, academic, and philanthropic communities. The evening convened a vibrant network of people whose attendance reinforced the shared belief that, when supported by funding and connected to collaboration, science has the power to improve lives and shape a better future.

Serving as Dinner Chair, Seema Kumar, the CEO of CURE and member of the Academy’s Board of Governors, opened the evening by reflecting on the Academy’s 200-year legacy of advancing discovery through convening the people and ideas that catalyze innovation and champion science in the service of society.

A Call to Supporting Science in Challenging Times

(Left to right) Brandon Regan, PhD, and Rose Faghih, PhD, faculty from NYU Tandon School of Engineering; John Kim, CLO of Cognizant; Academy Board Member, Chandrika Tandon; Janaki Bakhle, PhD from UC Berkeley; Sribala Subramanian, Columnist with The Diplomat; Ravi Kumar, Cognizant CEO, and Jatin Dalal, Cognizant CFO.

Academy President and CEO Nicholas Dirks welcomed guests to the Spring Soirée by underscoring the importance of advancing science for the public good, particularly amid global uncertainty and declining trust in institutions. He emphasized the role of science in combating misinformation, and fostering progress: “Science gives us the tools to understand complexity rather than fear it… and reminds us that progress — real, durable progress — is built not on ideological prejudice, but on free inquiry, collaboration, and trust.” Prof. Dirks also highlighted the responsibility of the scientific community to engage with the public and ensure the responsible use of emerging technologies. He thanked the Academy’s supporters, noting that the Spring Soirée is both a celebration and the Academy’s most important fundraising event, enabling continued investment in science and future generations.

In line with the evening’s fundraising efforts, Pat Tully, one of New York City’s top auctioneers, led the Soiree’s auction featuring exclusive experiences, including:

  • Behind-the-scenes scientific tours from Wildlife Conservation Society, Cornell Tech’s Tata Innovation Center, and NYU Langone Health’s Neuroscience Institute;
  • A rare Axiom spaceflight mission Ax-4 flown collectible;
  • A getaway from Prospect Berkshires;
  • High-demand tickets for a “Night at the Museum” conducted at the American Museum of Natural History; and
  • A unique opportunity to dine with Nobel Laureate and Academy Board member Michael Young.

The Soiree’s Award Winners

Throughout the evening, the Academy honored six award recipients whose work exemplifies leadership and service to society.

Inaugural Constellation Award

Prof. Dirks introduced the Soiree’s first honoree, Josh Lerner, PhD, the Jacob H. Schiff Professor at Harvard Business School and Co-Director of the HBS Private Capital Project, as the recipient of the Inaugural Constellation Award. Lerner was honored for his leadership in strengthening the relationship between scientific innovation and private capital in partnership with the Academy. Highlighting the critical importance of intersecting science and capital, Prof. Dirks said: “We believe forging stronger relationships between knowledge and capital has the potential to accelerate scientific breakthroughs… especially at a time when federal support for science is so uncertain.”

(Left to right) Peter Salovey, Josh Lerner recipient of the Inaugural Constellation Award, and Nicholas Dirks.

Visionary Award

Maria Gotsch, MBA, President and Chief Executive Officer of the Partnership Fund for NYC, was recognized with the Academy’s Visionary Award for her leadership in building New York City’s fintech and life sciences ecosystem, demonstrating how capital, when aligned with purpose, can transform entire sectors. She was introduced by Kathryn Wylde, the former president of the Partnership for NYC, an organization that has worked to advance New York City’s role as a global center of economic opportunity, upward mobility, and innovation. Wylde highlighted Gotsch’s leadership in supporting small businesses — from helping those displaced after 9/11 to safely reopening neighborhood businesses during the COVID-19 pandemic.

(Left to right) Kathryn Wylde, Nicholas Dirks, and Maria Gotsch, Visionary Award Recipient.

Cognizant STEM Awards

After Peter Salovey, PhD, the Chair of the Academy’s Board of Governors, recognized the Academy’s Board members for their stewardship, he introduced the Cognizant STEM awards. “We all know how essential it is to grow the talent pipeline… and create a sense of belonging and shared commitment to harnessing the power of science for the good of humanity.” Newly sponsored by Cognizant — the Cognizant STEM Teacher of the Year and Cognizant STEM Mentor of the Year — were jointly conferred by Cognizant’s CFO, Jatin Dalal, and Chief Legal Officer John Kim. Rocheli Apilan, a teacher at the High School for Health Professions & Human Services, was named Cognizant STEM Teacher of the Year. Samay Garg, PhD, from Columbia University’s Department of Chemical Engineering, was named Cognizant STEM Mentor of the Year. Both were honored for their personal investment in developing the next generation of scientists through the Academy’s STEM education programs.

(Left to right) Cognizant’s Jatin Dalal and John Kim with Cognizant STEM Award recipients, Samay Garg and Rocheli Apilan, with Peter Salovey.

Trailblazer Award

In a memorable introduction, New York University’s President Linda Mills touted the Academy’s Trailblazer Award recipient, John Sexton, PhD, President Emeritus of NYU and former Academy Board member, for his bold and unconventional leadership. “There are leaders who steer institutions — and then there are those who chart entirely new paths… John didn’t just follow the trajectory of higher education — he redrew the map.” She reflected on Prof. Sexton’s visionary creation of NYU Abu Dhabi and the risks inherent in true leadership, “Blazing a trail is not tidy work. It requires risk, improvisation, and the willingness to move forward even when the path isn’t clear.”

NYU President Linda Mills and Seema Kumar present John Sexton with his Trailblazer Award.

Science Communicator Award

Multiple Emmy®-award-winning Chief Medical Correspondent for CNN and practicing neurosurgeon, Sanjay Gupta, MD, was honored with the Academy’s Science Communicator Award for translating complex medical science into accessible, trusted insights, including during natural disasters and global health crises. Dr. Gupta’s mentor and colleague, Dan Barrow, MD, who serves as The Pamela R. Rollings Professor & Chairman of the Department of Neurological Surgery at Emory University School of Medicine, conferred the award. Speaking to Gupta’s two-decade history of health and medical reporting for CNN, Dr. Barrow said, “It’s a strange thing to introduce someone who has already introduced himself to the entire country.” Barrow highlighted Gupta’s rare ability to connect science and the public, “He understood something that far too many science communicators never quite figure out: the goal isn’t to impress. It’s to illuminate!”

Dr. Sanjay Gupta, recipient of the Science Communicator Awards, with Dr. Dan Barrow and Seema Kumar.

A Night Supporting the Future of Science

Closing out the evening, Soirée Dinner Chair Seema Kumar, reminded guests of the deeper purpose behind the Academy’s Spring Soirée, “The power of science is not just to discover, but to make a difference, because ultimately, progress is not defined by discovery alone, but by what we do with it.”

The Soirée was made possible through the generous support of Simons Foundation International, Cognizant, CURE, CNN, IBM, Partnership Fund for New York City, Roc360, Royalty Pharma, Johnson & Johnson, Leon Levy Foundation, Pfizer, Academy board members Laura B. Sachar and Chandrika Krishnamurthy Tandon, New York University, Yale University, and many other gracious partners.

The Societal Risks of AI

June 30, 2026 | 12:00 PM – 1:00 PM ET

AI safety, once a niche concern, is now a topic that the average person has heard of, but many remain unaware of the specifics and what can be done to safeguard against these new threats.

This webinar explores AI safety as both a technical and societal challenge. On the technical side, issues such as robustness, alignment, interpretability, and controllability raise fundamental questions about how we design systems that behave as intended. On the societal side, concerns around misuse, systemic bias, economic disruption, and governance highlight the broader implications of deploying AI at scale. These dimensions are deeply interconnected: technical design choices can have far-reaching social consequences, while policy decisions can shape the trajectory of technical development.

The goal of this webinar is to provide a structured overview of key problems, current approaches, and open research directions in AI safety.

Lyceum Society: Two Views of Evolution: In Space and On Earth

An abstract graphic.

May 4, 2026 | 11:30 AM – 2:30 PM ET

Presented by the Lyceum Society

To attend, click the “Register” button at the time of the presentation. It will take you directly to the Zoom call.


Welcome and Introductions: 11:30 AM to 11:45 AM

Main Presentation: 11:45 AM to 2:30 PM

Two Views of Evolution: In Space and On Earth

Part One: The wonder of the original creation and history of the universe—the physics of it—will be presented by Stuart Kurtz. This will include some radical new discoveries that show we may be on the verge of a scientific/physics revolution not seen since Einstein.

Part Two: Bill Rosser will address some dimensions of evolution on Earth, specifically (1) three rules of biological evolution; (2) a non-evolutionary example, which is the creation of language—unique to humans—which is fundamental to linguistic anthropology; and (3) the continuing growth of appreciation of our magnificent universe and which, for many in science and beyond, has developed a strong spiritual source for developing broader awareness, guiding behavior, and/or the imagining of our collective future. Example: the Deeptime Network organization.

Discussion will follow. The insights gained from our session will be used to pursue explorable topics for a newly forming, informal special-interest group, with focuses such as “Survival and the Evolution of Creative Potential, Resilience, and Antifragility,” “Resourcefully Countering Accelerating AI,” and “Linguistic Anthropology and The Wide World of Mathematical Linguistics.”

Pricing

All: Free

About the Series

The Lyceum Society is a collegial venue promoting fellowship, education, and discussion among retired members of The New York Academy of Sciences. Learn more and explore other events hosted by the Lyceum Society.

Chemical Biology: Peptide and Protein Design

Engineered peptides and proteins have revolutionized how scientific researchers interrogate biology as well as how clinicians treat disease. Over the last couple of decades, chemists and biologists have developed new ways to modify peptides and proteins that can improve their specificity, enable switchability, and enhance their pharmacological properties.

The Chemical Biology: Peptide and Protein Design conference will explore the latest research on “designer” peptides and proteins, and how chemists and biologists alike are using these specialized biomolecules as tools to understand biological mechanisms and as therapeutics to treat human disease.

This program highlights keynote speaker Sam Gellman, PhD from the University of Wisconsin-Madison as well as plenary presentations from both academic and industry researchers. Together, these talks will explore topics such as therapeutics inspired by nature, high-throughput viral display, and non-traditional strategies for targeting oncogenic signaling pathways. In addition, a selection of early-career researchers will have the opportunity to share their innovative work in peptide and protein design through short talks and poster presentations.

2026 Ross Prize Symposium: CAR-T Cells for Cancer and Beyond

A graphic representation of cells.

The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries have transformed how medicine is practiced.

The awardees are mid-career researchers who have significantly impacted the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.

The 13th annual Ross Prize in Molecular Medicine is awarded jointly to Drs. Carl June and Michel Sadelain for their pioneering work in developing CAR T-cell therapy for cancer treatment.

Dr. June’s and Sadelain’s complementary work has led to the groundbreaking form of personalized cancer immunotherapy that modifies T cells from a patient’s immune system with synthetic receptors called chimeric antigen receptors (CARs). These receptors enable them to recognize and selectively destroy cancer cells when infused back into the patient’s body. CAR T-cell technology has revolutionized how physicians treat leukemia, lymphoma, and multiple myeloma, and is now showing promise in treating autoimmune and infectious diseases.

Join us in celebrating Dr. June’s and Dr. Sadelain’s innovative, award-winning research on June 11th.

This hybrid symposium will include presentations from Dr. June and Dr. Sadelain on the integral facets of their work, plenary lectures, and in-person networking opportunities. Register today to participate in this incredible celebration of scientific innovation.

Sponsors

Presented By

This symposium is made possible by the generosity of Jack and Robin Ross with support from:

Logo for Feinstein Institutes for Medical Research
The logo for "BMC Springer Nature Molecular Medicine"
The New York Academy of Sciences logo

Academy’s Past – Right Up There on Broadway

A screen shot of Jay Z from the Empire State of Mind music video.

The New York Academy of Sciences found its current home with a move to 115 Broadway in May 2023. The building has its own unique history dating back more than a century.

Published March 23, 2026

By Nick Fetty

A 1906 shot of the Trinity and U.S. Realty Buildings. Image via University of Michigan Library Digital Collections.

The United States Realty Building | 115 Broadway | 2023-Present

The site of The New York Academy of Sciences’ current home at 115 Broadway has an intriguing history dating to the American Revolution.

Construction on the U.S. Realty Building (115 Broadway) was finished in 1907, two years after completion of the nearly identical Trinity Building (111 Broadway) directly to the south. The 21-story, steel-framed, Indiana limestone, Gothic-revival buildings were considered early examples of New York City skyscrapers. The two buildings were designed to complement the aesthetic of Trinity Church, immediately to the south.

Some accounts, such as from The New York Times’ Christopher Gray, dubbed the two buildings as the original “twin towers.” These buildings, which graced the city skyline during an era when the tallest structures were concentrated in Lower Manhattan, were designated New York City landmarks in 1988.

The two structures are nearly identical in design, with the exception of a five-story cupola atop the Trinity Building. Combined, the two buildings encompassed more than half a million square feet “with [in 1907] an average annual rental of $3 a per [sic] square foot for Trinity and $2.75 a square foot for the U. S. Realty Building”. The lack of the view of the Trinity Church cemetery (three blocks south) was cited as the reason for the lower rental costs, contrary to the notion that cemetery views lower real estate prices.

“The Father of the Skyscraper”

Both buildings were designed by Francis Kimball, the famous New York architect with projects such as the still standing Empire Building, 71 Broadway, (not to be confused with the Empire State Building), and the now-defunct Casino Theatre, 1404 Broadway and West 39th Street, to his name. An American by birth, Kimball was inspired by Gothic revival architecture while visiting London in the 1870s. He was dubbed “The Father of the Skyscraper” by The New York Times in 1917, two years prior to his death. Many of Kimball’s skyscrapers utilized a then-new engineering development known as “caissons,” which are retaining structures used when building bridges and the base of large buildings.

The two buildings include several impressive architectural features such as limestone gargoyles and brass dragons perched around the exteriors as well as double height basket-arched windows at the base of each. Each building has an entryway adorned with Sienna Marble and white statuary marble imported from Italy. The entryway’s high, arched ceilings and stained glass interior windows give the feel of a “European house of worship” while gilded grotesques – some smiling, some frowning – peer down on building tenants and guests as they wait for the elevator.

The History of the Site

The U.S. Realty Building is located approximately six blocks south of the Academy’s first home near Barclay and Broadway during the 19th century. At this time (1817), the City Hotel stood approximately where the U.S. Realty Building stands today. It was among the grandest hotels in the city during this era with more than “one hundred large and small parlours and lodging-rooms” as well as a concert/banquet hall.

Prior to City Hotel, the site was home to a tavern that served as a meeting spot for the Sons of Liberty in 1765 as they planned a resistance to the British Stamp Act. It was also the location for George Washington’s 1789 inaugural ball. Fast-forward two centuries, and the building makes an appearance in the music video for Jay-Z and Alicia Keys’s 2009 anthem “Empire State of Mind.”

The U.S. Realty Building, the Trinity Building, and the spire of Trinity Church can be seen around the 1:41 mark in the music video of “Empire State of Mind.” Screenshot via S. Carter Enterprises/YouTube.

The Academy moved into its new facility in May 2023. An Open House reception was hosted on Sept. 14, at which 200 scientists and science enthusiasts had the opportunity to tour the space. The Academy’s new home hosts dozens of Academy events (hybrid and in-person) throughout the year and is available for rent by the public.

“My hope is that we become not only the virtual go-to space but we actually become the physical go-to space where people think ‘this is the place where I can hang out, I can interact with really interesting, smart people, I can engage in conversations that reflect the Academy’s fundamental purpose,’” Academy President and CEO Nick Dirks said during the 2023 open house.

This is the final piece in an eleven-part series exploring the Academy’s past homes. Read:

6 Famous Non-Scientists with Ties to the Academy

A portrait of U.S. President Thomas Jefferson.

Actors, a past president, and even a “world champion” racer. Here are six famous non-scientists with ties to The New York Academy of Sciences.

Published March 19, 2026

By Nick Fetty

For more than 200 years, the academy has prided itself on its egalitarian and democratic roots. Anyone with an interest, even curiosity, in science could become a member. This includes celebrities as well as those who wouldn’t be considered scientists in the traditional sense.

Here are six non-scientists with ties to the Academy, listed alphabetically.

Fernando Alonso, Formula One Racer

It’s not every day that a “world champion” visits the Academy. But that’s exactly what happened when two-time Formula One titlist Fernando Alonso visited in 2012.

Alonso gave a speech to motorheads and other attendees during an event at the Academy’s former office on the 40th floor of 7 World Trade Center. At this point in his career he was racing for Ferrari, the Italian luxury sports car manufacturer that dominates the world of F1 racing. Appropriate for a talk at the Academy, Alonso focused on the STEM aspects of racing and automotive performance.

“I think there is never enough technology,” he said, according to reporting from the London-based Daily Telegraph. “Technology is our motivation and the main goal for engineers and designers.”

The Spaniard won the world titles in 2005 and 2006 while racing for French-based Renault. He has since joined the Aston Martin Aramco Formula One Team and is geared up for the start of the 2026 race season. He’s driving a new car designed by British engineer Adrian Newey, “the most successful car designer in F1 history.”

The 2026 race season got underway earlier this month with the Qatar Airways Australian Grand Prix.

Salvador Dalí, Artist

Fellow Spaniard, artist Salvador Dalí, also has an Academy connection.

Part of the surrealistic art movement of the 20th century, Dalí was known for his “eccentric behavior and his eerie paintings.” His 1931 painting The Persistence of Memory depicts a realistic landscape with surreal melting clocks, a scene that a brain under the influence of hallucinogens might conjure up (see Aldous Huxley section below.)

The late Adnan Waly, PhD, a German-born nuclear physicist and longtime Academy member, recalled when the Spanish surrealist made a surprise appearance at an Academy event.

“I was at the Academy attending a lecture of the Nuclear Section. I found a seat in an empty row because not too many people were interested in nuclear physics at the time. The door opened, and in came a gentleman flanked by two gorgeous women. It was Salvadore Dalí with his moustache and his cane. He sat in my row with the ladies, and he put his cane up, two hands on the cane and his chin resting on it, as was his habit. He looked at the pictures that were presented,” Dr. Waly recalled.

“One of the pictures was of a cloud chamber — a photograph of particles moving apart from a center,” Dr. Waly continued. “Some time afterwards I saw a television program where Dalí was interviewed, and his latest painting was exactly what he had seen at the Academy, with tracks coming out from the center. ‘You don’t know what this is?’ Dalí said to the interviewer. ‘These are pimmesons.’ The lecture had been on the π meson.”

Dalí passed away in 1989 at the age of 84. Today the Academy continues its long, proud history of combining the arts and the sciences. This includes events with artists and providing space for works to be exhibited.

Michael J. Fox, Actor

Known for starring roles in 1980s classics like Back to the Future and Family Ties, Michael J. Fox’s acting career was forever changed by his Parkinson’s disease (PD) diagnosis at the age of 29.

Instead of sitting on the sidelines, Fox took an active role in advocating for the disease. In 2000, shortly after going public with his diagnosis, he founded the Michael J. Fox Foundation for Parkinson’s Research. To date, the organization has raised more than $2.5 billion to support research.

Fox’s foundation teamed up with the Academy in 2007 to host the inaugural PD Therapeutics Conference. The event was “the first and only major scientific symposium exclusively focused on the development of innovative drugs to target Parkinson’s disease.”

In addition to his advocacy and despite his condition, Fox continued to act. He voiced lead roles in multiple movies and has made various guest appearances on television. His appearance on HBO’s Curb Your Enthusiasm served as a chance to use humor to teach viewers about PD.

“It has long been recognized that humor can help those suffering from chronic conditions better cope with their diseases, and any chance to increase awareness of Parkinson’s disease among the general public is important,” Dr. Cheryl Waters of the Neurological Institute at Columbia University Medical Center told ABC News in 2011.

Though his condition has worsened to the point that he is now officially retired from acting, Fox remains optimistic that with adequately funded science a cure is possible.

“I know we’ve done a lot, but we haven’t cured Parkinson’s,” Fox told TIME magazine earlier this year. “I’m always pushing and never happy until we get this done. We’ve changed the way people think about the disease, and we know there’s an end, and we’ll find it.”

Aldous Huxley, Author

A black and white photo of people during at conference at The New York Academy of Sciences in the 1950s.
Aldous Huxley (seated, left) during a 1956 conference at the Academy.

The English-born writer and philosopher is perhaps best known for works like Brave New World (1932) and The Doors of Perception (1963). Though less known, Aldous Huxley is also tied to what’s believed to be the first public utterance of the term psychedelic.

Huxley befriended Humphry Osmond, a psychiatrist researching the therapeutic potential of substances like LSD in the 1950s. He was known to supply Huxley with hallucinogens like LSD and mescaline.

In 1956, Huxley delivered a keynote address at an Academy conference in which he predicted that “drugs [like Meprobamate] were capable of changing the quality of human consciousness.” The following year, he authored a piece entitled “The History of Tension” published in Annals of the New York Academy of Sciences. The piece, in part, detailed the cultural history and application of substances like hallucinogenic mushrooms and peyote.

“Meanwhile, all that one can predict with any degree of certainty is that it will be necessary to reconsider and re-evaluate many of our traditional notions about ethics and religion, and many of our current views about the nature of the mind, in the context of the pharmacological revolution,” Huxley concluded. “It will be extremely disturbing; but it will also be enormous fun.”

Huxley passed away on November 4, 1963, the same day as fellow British writer C.S. Lewis, author of The Chronicles of Narnia (1950-1956). Both deaths were overshadowed by the assassination of U.S. president John F. Kennedy.

Appropriate for the man co-credited with coining the term psychedelic, Huxley had one dying wish. “At his request,” New York Magazine reported, “his wife shot him up with LSD a couple of hours before his end, and he tripped his way out of the world.”

Thomas Jefferson, 3rd President of the United States

Thomas Jefferson was a Founding Father and the third president of the United States.

A true renaissance man, Jefferson’s interests and skills were boundless. Even within the then-relatively young field of science, he dabbled in everything from architecture and agriculture to astronomy and paleontology. An inventor too, he developed an improved concept for a field plow, believing that “agriculture was the most important science, understandable since agriculture was the backbone of human civilization at the time.”  Jefferson even had the foresight to identify areas that could be better understood through the practice of science.

“The botany of America is far from exhausted, its mineralogy is untouched, and its zoology totally mistaken. We have spent the prime of our lives in procuring your students the precious blessing of liberty. Let them spend theirs in showing that it is the great parent of science and of virtue, and that a nation will be great in both ways in proportion as it is free,” Jefferson wrote in a letter to the Harvard University president in the early 19th century.

With his diverse interests and proven success as a leader, it was only natural to enlist his expertise when the Lyceum of Natural History (which changed its name to The New York Academy of Sciences in 1876) was established in 1817. Jefferson was among five other dignitaries elected “honorary members” in 1817. Samual Mitchell, the Academy’s first president once said that “he supported the Republican Party because Mr. Jefferson was its leader, and supported Mr. Jefferson because he was a philosopher.”

While some of Jefferson’s views and actions would without doubt be considered insensitive (to put it mildly) today, he nonetheless played a significant role in shaping the United States, the Academy, and science broadly.

Christohpher Reeve, Actor

Like fellow actor Michael J. Fox, Christopher Reeve’s career began on the silver screen before he became a science advocate.

Born in NYC, Reeve studied at Cornell University and Julliard, before getting his breakthrough as Superman in the eponymous 1978 film. He went on to play the red-and-blue-decked DC Comics superhero in the three subsequent films in the 1980s.

At six-foot-four with an athletic build, Reeve physically embodied the part of a superhero. He even “performed many of his [own] stunts, including dangerous ‘flying’ exercises,” according to a 2004 CNN article. But Reeve’s life took a drastic and unexpected turn when a 1995 horse-riding accident paralyzed him from the neck down.

Following the accident, Reeve required a wheelchair to move and a respirator to breathe. Around this era, stem cells and cloning were emerging as potential, albeit ethically controversial in some circles, methods for repairing damaged tissues and organs. The conservative George W. Bush administration at this time opposed federal funding for embryonic stem cell research.

During an event at the Academy in May 2002, Reeve, an advocate of stem cell research, debated James Kelly, who presented an apprehensive take on the new treatment. Kelly, who was paralyzed in a car accident, felt that “using human eggs to treat injury and disease is too far in the future, too costly, and would divert funding from more promising research,” according to a 2002 article from the Knight Ridder news service.

Reeve retorted that “therapeutic cloning is different from reproductive cloning.” He suggested that U.S. policy around the matter should take a “strictly regulated” approach like England. Despite the at-times contentious debate, events like this highlight the need for earnest discussions from various viewpoints, to advance science.

Christopher Reeve passed away just two years after the event, at the age of 54.

Not a member of this inclusive and impactful community? Join the Academy today.

Lyceum Society: Evolution and the Rise of Creative Potential

An abstract graphic.

April 6, 2026 | 11:30 AM – 2:30 PM ET

Presented by the Lyceum Society

To attend, click the “Register” button at the time of the presentation. It will take you directly to the Zoom call.


Welcome and Introductions: 11:30 AM to 11:45 AM

Main Presentation: 11:45 AM to 2:30 PM


Our April Program has four parts. The overall moderator is our president, Clif Hotvedt.

1. REVIEW OF PROGRAM GROWTH FOR THE PAST 12 MONTHS, AND PLANNING FOR NEXT SEASON

We will introduce our resourceful Lyceum Planning Team: Chairman, Phil Apruzzese, Bill Rosser (VP), Stuart Kurtz, Uldis Blukis, and Herb Klitzner. Each person on this team has given numerous talks to Lyceum over the years. In addition, together, the team has developed new concepts for talks, such as our successful periodic “Making of a Scientist” series and our annual “Nobel Prize Winners” sensitive profiles.

2. EVOLUTION AND THE RISE OF CREATIVE POTENTIAL

We will discuss and develop our scheduled May 4 Talk on the topic of Evolution of Creativity, Resilience, and “Anti-Fragility,” producing unusual individuals of different kinds to truly rescue society in times of crisis, when conventional tools fail in the face of a new challenge. Bill Rosser will organize and lead the discussion. Bill is our Lyceum VP and was a senior executive at Gartner Group, the leading market research firm in emerging computer technologies.

As part of our discussion, to help us understand this process of rescue, Stuart Kurtz, world-traveled chemical engineer and interpreter of the science endeavor will share with us an important example from the History of Science – the growing  “Nitrogen Fertilization Shortage” from the late 1800s to 1913 just before the opening of WW 1.

In addition, Jean Smith, a planner at the Science Discussion Network of the Unitarian Universalist Congregation at Shelter Rock, in Manhasset, Long Island, will describe her unique experience in resourcefully applying scientifically based deeply creative techniques to first understand and then solve a serious infection that had been diagnosed as untreatable. As part of her process of evolving a successful treatment for herself, she created a Facebook group of eventually 8,000 people whose conditions resembled her own, along one dimension or another, helping them to move forward in their own lives.

3. OTHER NEW PROGRAM HIGHLIGHTS

We will also examine three other pivotal subject area clusters, listed below. To explore possibilities, we will sample one specific topic to focus on next season from each of the three clusters:

  • BioMed/Pharma/Physical Therapy (PT).
  • AI, Math, Values, Human Development, Psychology, the Science of Aesthetics, and the Designing of Future AI-Customized Tools.
  • History of Science, and the Connectedness of Science and Culture.
4. OPEN DISCUSSION

At the last part of our meeting, we will open up the discussion to the audience for further comments and suggestions. Please join us with your ideas in this special future-oriented program discussion.

Pricing

All: Free

About the Series

The Lyceum Society is a collegial venue promoting fellowship, education, and discussion among retired members of The New York Academy of Sciences. Learn more and explore other events hosted by the Lyceum Society.

Mitochondrial Health and Healthspan: Brain Metabolism and Bioenergetics

An abstract graphic.

Mitochondrial Health and Healthspan: Brain Metabolism and Bioenergetics will bring together leading researchers and clinician-scientists to explore the central role of mitochondria in brain function, resilience, and aging. Once viewed primarily as cellular powerhouses, mitochondria are now understood to regulate signaling, inflammation, gene expression, and neuroplasticity. Their influence spans development, stress adaptation, metabolic regulation, and neurodegenerative disease, positioning mitochondrial biology at the forefront of efforts to extend healthspan and preserve cognitive vitality.

The symposium will highlight advances across three interconnected themes. Mitochondrial Genetics and Cellular Signaling in Brain Health will examine how mitochondrial DNA variation and bioenergetic function shape neural performance and disease risk. Mitochondrial Psychobiology: Stress, Development, and Neuroplasticity will explore how stress and early-life experiences influence mitochondrial dynamics and long-term mental health. Metabolic Psychiatry and Mitochondrial Therapeutics: From Diet to Drug Development will focus on emerging nutritional, metabolic, and pharmacologic strategies to target mitochondrial pathways implicated in psychiatric conditions.

Through keynote and plenary presentations, participants will gain insight into mechanisms linking mitochondrial dysfunction to cognitive decline, mood disorders, neurodevelopmental conditions, and neurodegeneration. Emphasis will be placed on translational opportunities, including biomarkers and precision interventions that move from discovery to therapeutics. Join us on November 11, 2026, for a focused and forward-looking discussion at the intersection of bioenergetics, brain science, and healthy aging.

Sponsors

Presenting Partners

The New York Academy of Sciences logo

Advancing Tyrosine Kinase Inhibitors from Discovery to Patient Care: The Dr. Paul Janssen Award Symposium

The Dr. Paul Janssen Award Symposium celebrated the groundbreaking achievements of Dr. Anthony “Tony” Hunter, PhD, American Cancer Society Professor and Renato Dulbecco Chair at the Salk Institute for Biological Studies in La Jolla, California. This symposium brought together leading voices in cancer research and biomedical innovation to honor Dr. Hunter’s pioneering work and explore its profound impact on modern science and medicine.

Go to the event page